Skip to main content
APhA 2024 Annual Meeting and Exposition Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Megan Ehret, PharmD, MS, BCPP (she/her/hers)

Professor and Co-Director of Mental Health Program
University of Maryland School of Pharmacy
Baltimore, Maryland, United States

Dr. Ehret is a graduate of the University of Toledo where she completed her BS and PharmD degrees, and she went on to complete a Psychiatric Pharmacy Residency at the Louis Stokes VAMC, under the direction of Matthew Fuller. She then completed a Psychopharmacology and Pharmacogenomics Fellowship at Nova Southeastern University, under the direction of Gary Levin. After training she received her initial faculty appointment at the University of Connecticut and gained tenure during her stay there. While at the University of Connecticut, Dr. Ehret served as the Vice-Chair of the IRB, Director of Practices for the Center for Correctional Health Networks, and a faculty member for Project: ECHO: Buprenorphine. Currently, her full-time role is a Professor and Co-Director of the Mental Health Program at the University of Maryland School of Pharmacy with a practice site at The University of Maryland Mid Town Campus. Additionally, she also has the privilege of working with the State of Maryland Medicaid Program in evaluating antipsychotic use in the state and reviewing psychotropic use in the pediatric population. She is a Past-President of AAPP and is the current BCPP Recertification Director. Dr. Ehret has worked with the State of Maryland to establish regulations permitting community pharmacists the authority to administer maintenance injections. She has developed an interactive training program for students in administering long-acting injectable medications. Dr. Ehret has numerous publications and book chapters describing psychotropic medication adherence and the role of pharmacogenomics in medication selection. Her current interests include psychotropic medication adherence and the advancement of the psychiatric pharmacist in practice.

Disclosure(s): Saladex Biomedical LLC: Consultant (Ongoing)

Presentation(s):

Email Megan